This article is our annual attempt to highlight the key papers written in the prior 12 months (i.e., between July 1, 2021, and June 30, 2022) in which digital health technologies were used to provide digitally driven care for patients with diabetes mellitus or prediabetes. This article addresses both digital therapeutics and digital care solutions. Digital therapeutics deliver evidence-based interventions to an individual, either independently or in combination with other therapeutics (e.g., drugs, devices, and behavioral interventions).
